21-22 February, 2017
Philadelphia

Sponsorship Opportunities

The 2nd Biosimilars Clinical Studies and Analytical Similarity Summit, will bring together pharmaceutical executives to discuss effective biosimilar development processes to tackle frequent challenges with pre-clinical/analytical, clinical studies and marketing issues.

With the biosimilars market projected to be worth $32 billion by 2025, according to the Global Biosimilars Market, gaining a competitive advantage is very critical. Manufacturing complexities and regulatory ambivalence are major pain points in the biosimilars industry and our audience is specifically looking for solutions to help them in these areas. Contact Me Today

Stephen Aponte
Sponsorship Marketing Manager
Phone: 212-885-2664
Email: Stephen.Aponte@IQPC.com

Streamline your sales and marketing efforts

Streamline your sales and marketing efforts by gaining access to stakeholders across the pharma and biotech industries under one roof, at one time!

Position your value and brand superiority above competitors

Network with our high-level speaker faculty and attendees.

ensure your capabilities are front-of-mind.

Position your value and brand ahead of competitors in the marketplace to ensure your capabilities are front-of-mind.

Leverage an intimate atmosphere to discuss

Leverage an intimate atmosphere to discuss your value proposition through a thought leadership presentation, reserved for select providers.

Leverage an intimate atmosphere to discuss

Align your objectives with a completely tailor-made sponsorship package in order to maximize your company's exposure.

As a Sponsor, your Company Will Receive Exclusive Access to Our Audience of Top VPs, Directors, and Leaders From Life Sciences! Take a look at the sample list of job titles that will be represented onsite:

 

Biosimilar Development

 

Clinical Research

 

Biosimilar Safety

 

Clinical Trial Supply

 

REgulatory Affairs

 

Public Policy-Biosimilars

 

Biosimilar Drug Products

 

Clinical Operations

 

Analytical Characterization

 

Pharmacovigilance

 

...plus more!


who should sponsor biosimilars